Connect with us

Health

Ontario reports more than 3,400 new coronavirus cases, 69 deaths – Global News

Published

 on


Ontario reported 3,422 new cases of the novel coronavirus Sunday, bringing the total number of cases in the province to 237,786.

“Locally, there are 1,035 new cases in Toronto, 585 in Peel, 254 in Windsor-Essex County, 246 in York Region and 186 in Niagara,” Health Minister Christine Elliott said.

A total of 203,484 COVID-19 cases are considered resolved, which is 85.6 per cent of all confirmed cases.

Sixty-nine more deaths were also reported Sunday, bringing the provincial death toll to 5,409.

Read more:
Canada’s cases of COVID-19 have surpassed 700K

Nearly 60,200 additional tests were completed. Ontario has now completed a total of 8,925,446 tests and 30,103 remain under investigation.

Story continues below advertisement

The province indicated that the positivity rate for the last day was 5.2 per cent, which is up from Saturday’s report, when it was 4.9 per cent, and down from last Sunday’s when it was 6.2 per cent.

Provincial figures showed there are 1,570 people hospitalized with the virus (down by 62), with 395 in intensive care (down by two), and 293 on a ventilator (up by 12).

However, the province noted that more than 10 per cent of hospitals did not submit their daily bed census for Sunday’s report — as is often the case on weekends — likely causing the reported number of hospitalizations to be lower than it actually is.






2:01
Coronavirus: Critically ill patients flown to other regions due to ICU bed shortage


Coronavirus: Critically ill patients flown to other regions due to ICU bed shortage

Here is a breakdown of Ontario’s cases by age and gender:

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

  • 116,156 people are male
  • 120,275 people are female
  • 31,106 people are 19 and under
  • 86,966 people are 20 to 39
  • 68,473 people are 40 to 59
  • 34,232 people are 60 to 79
  • 16,959 people are 80 and over

The province notes that not all cases have a reported age or gender.

Story continues below advertisement

The province also notes that the number of cases publicly reported each day may not align with case counts reported by the local public health unit on a given day. Local public health units report when they were first notified of a case, which can be updated and changed as information becomes available. Data may also be pulled at different times.

According to the Ministry of Long-Term Care, there have been 3,123 deaths reported among residents and patients in long-term care homes across Ontario, which is an increase of 11. There are currently 246 outbreaks in long-term care homes.

There are 1,622 active cases among long-term care residents and 1,313 among staff.

As of 8 p.m. Saturday, 200,097 COVID-19 vaccine doses have been administered in Ontario, marking an increase of 11,007 from the previous day. So far, 21,714 people have received both required doses.

Story continues below advertisement

Story continues below advertisement

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canadian experts caution against temptations to comparison shop COVID-19 vaccines – Kelowna Capital News

Published

 on


While it’s tempting to compare various aspects of AstraZeneca-Oxford’s newly approved COVID-19 vaccine to others, several experts cautioned against focusing on data that is not comparable and the danger of underrating the product’s ability to curb hospitalizations and deaths.

Health Canada’s long-awaited announcement Friday that a third vaccine would soon be deployed came just as the provinces faced heightened scrutiny over regional immunization plans that vary by timeline, age eligibility and priority groups.

Prime Minister Justin Trudeau promised the boost to Canada’s pandemic arsenal would mean “more people vaccinated, and sooner,” and would be key to helping contain spread.

Nevertheless, Health Canada chief medical advisor Dr. Supriya Sharma acknowledged questions over how the public should evaluate trial results that show AstraZeneca has an efficacy of 62 per cent in preventing symptomatic cases. That’s compared to the 95 per cent efficacy of the country’s two other approved vaccines, from Pfizer-BioNTech and Moderna.

But Sharma stressed that all three have been shown to prevent 100 per cent of hospitalizations and deaths due to COVID-19.

“Each vaccine has unique characteristics and Health Canada’s review has confirmed that the benefits of the viral vector-based vaccine, as with the other authorized vaccines, outweigh their potential risks,” Sharma said.

Several medical experts including Dr. Stephen Hwang say Canadians do not have the luxury to pick-and-choose as long as COVID-19 cases continue to rage in several hot spots and strain health-care systems.

With multiple COVID-19 projections warning of a variant-fuelled third wave without tighter suppression measures, any tool that can slow the pandemic should be embraced, he argued.

“It would be important for people to be vaccinated with whichever vaccine is first available in their community to them, rather than trying to hold out for a specific vaccine,” advised Hwang, who treats COVID-19 patients at St. Michael’s Hospital in Toronto.

Still, Toronto resident Maria Brum couldn’t help but question whether AstraZeneca was safe for her 79-year-old mother.

The vaccine was not tested on people over the age of 65. Health Canada, however, says real-world data from countries already using the product suggest it is safe and effective among older age groups, promising an update on efficacy in the age group as more data comes in.

“I personally would take that one out as an option for my mom,” said Brum, who is her mother’s main caregiver.

“Maybe I am wrong but, I don’t know, I don’t see that it’s more useful. I’d like to see one that has a higher percentage of (efficacy).”

As for herself, Brum said she has allergies that she believes may put her at greater risk of adverse reactions and so she is unsure whether she can take any vaccine.

But she’d like the option of choosing, if possible, even while acknowledging that limited supply could make that unlikely.

“As a Canadian, I would like to see us all have choices, regardless of age, gender, or ability,” says Brum.

“I’m going to wait where I can have more choices.”

Such hesitancy could pose public health challenges to Canada reaching the vaccination coverage needed to build protective immunity against COVID-19, said Hwang.

He noted that Germany has seen a reported preference among some for the vaccine made by Germany’s BioNTech with Pfizer, as well as a misconception that the AstraZeneca vaccine is inferior because of a lower efficacy rate.

Hwang says efficacy between vaccines cannot be compared because each involved completely different trials at different time periods, in different countries, with different volunteers of different age groups and varying trial designs.

“Until we have direct comparison studies where we give people one vaccine versus another and directly compare, it’s very difficult to know for sure how it’s going to pan out,” he says.

Then there’s the fact Canada’s initial AstraZeneca doses will be made at the Serum Institute of India, which dubs its version CoviShield, while later packages will be produced at the drug giant’s own manufacturing facilities.

Hwang acknowledges that could invite further scrutiny but says the Pune, India-based biotech firm has a “strong track record of producing vaccines.”

Sharma also stressed the similarities between the two shots Friday.

“For all intents and purposes they’re the same vaccine,” said Sharma.

“There are some slight differences in terms of manufacturing and the places that they are manufactured are different. The analogy is a bit like the recipe – so the recipe for the vaccine is the same, but they’re manufactured in different kitchens.”

Coronavirusvaccines

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Health

US urges Tanzania to embrace COVID-19 vaccines, share data – Burnaby Now

Published

 on


NAIROBI, Kenya — The United States praised Tanzania on Friday for finally acknowledging the resurgence of COVID-19 after claiming for months it had defeated the pandemic through prayer. But the U.S. urged the country to share infection data and accept vaccines.

“It has become clear that the virus variant has arrived in Tanzania,“ U.S. Ambassador Donald Wright, who is also a doctor, said in a statement. “I’ve been encouraged by recent statements from the Ministry of Health acknowledging COVID-19 as a public health priority in Tanzania and urging citizens to take basic precautions.“

Tanzania is one of Africa’s most populous countries, with some 60 million people, and during its long COVID-19 denial the director of the Africa Centers for Disease Control and Prevention warned that if the continent isn’t united, “it’s doomed.”

High-profile deaths this month in the East African nation, including that of the vice-president of the semi-autonomous island region of Zanzibar, appeared to lead populist President John Magufuli to acknowledge publicly in the past week that COVID-19 was back.

For weeks, Tanzanians had seen a rise in death notices citing breathing difficulties and cases of what health workers called “pneumonia.” But countries such as Oman reported Tanzanians arriving in their countries and testing positive for the virus.

Meanwhile, Tanzania’s president openly questioned COVID-19 vaccines, without providing evidence. Tanzania is one of the very few countries in Africa that has not signed up for the global COVAX facility to provide vaccines to low- and middle-income countries. Now those vaccines have begun to arrive, in Ghana and Ivory Coast, with more on the way.

The U.S. ambassador’s statement urges Tanzania to “convene its health experts and review the evidence on vaccines.” He also notes “it is critical to collect and report information about testing and cases.“

Tanzania last updated its number of infections last April. That number remains at 509.

Then the ambassador turned to aid: “Here in Tanzania, we dedicated $16.4 million to mitigate the COVID-19 pandemic since the first confirmed case was diagnosed in March of 2020. The United States stands ready to ramp up our efforts and we are committed to working side by side with Tanzania to defeat COVID-19.”

An embassy spokesman did not immediately respond to a question about whether further aid depends on Tanzania sharing pandemic data and embracing vaccines.

Tanzania, unlike other African countries, did not lock down during the pandemic and it has promoted that to tourists and others.

In an interview with The Associated Press on Thursday, Tanzania’s investment minister, Kitila Mkumbo, asserted that COVID-19 “has not been one of the major concerns of investors.” He added that American investors “are waiting for the pandemic to slow down so movement can begin.”

And the minister welcomed the Biden administration, saying he believed that the U.S. will once again “take global responsibility of supporting developing countries like Tanzania in many aspects, like health.”

___

Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

Cara Anna, The Associated Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Vaccine centers embrace stickers and selfie stations – The Verge

Published

 on


The best picture I’ve seen this week was a selfie from my father-in-law who just got his first dose of a COVID-19 vaccine. Along with the shot, they gave him a sticker that says “I got vaccinated!”

As the vaccine rollout continues, clinics and distribution centers across the country are embracing things like stickers and even selfie stations decked out with colorful backgrounds to help people celebrate getting the shot.

The selfie stations are set up as colorful backgrounds, often with pro-vaccine messaging tiled with the name of the healthcare provider. It’s good branding. And hey, if social media-friendly backgrounds helped make some trendy restaurants popular, there’s no reason they couldn’t work for vaccine sites too.

Added bonus — if the vaccines are being given in a healthcare setting, it gives people a designated space to take pictures without compromising other patients’ privacy.

Vaccine stickers and selfies can increase confidence in vaccines. Just like “I voted” stickers were designed to remind people about Election Day, “I got vaccinated” stickers are designed to help people see the vaccination efforts unfolding in their own community.

Back in December, the Centers for Disease Control and Prevention developed stickers for healthcare workers to wear after they got vaccinated. Since they were some of the first people in the country to get vaccinated, the stickers were an easy way for workers to start conversations about the vaccines with their patients and colleagues — some of whom might be reluctant to get the vaccine.

The ready-made vaccination celebrations are also a way to dissuade people from sharing their vaccine cards on social media. Those can contain personal information, and posting photos of them can help scammers scam. A photo of your vaccinated self sporting a sticker, on the other hand, does not pose nearly as much of a privacy risk.

Stickers can serve the same purpose outside of the healthcare industry too. But also; they’re super fun. Slapping on a sticker is a chance to visually celebrate in a time when there’s been so little for us to enjoy. So is taking a selfie to share with the world. Sure, there are public health benefits to making vaccination visible. It’s also pure joy.

I’m not eligible to receive the vaccine yet where I am, and I probably won’t be for a long time. But after seeing so much death and suffering during the past year, it brings me nothing but hope and happiness to see the relief in people’s eyes after they get their shot.

Other people have been taking their vaccine celebrations into their own hands. Not content with the official offerings, they’re dressing in their best, donning sequins, and even bringing fun bandages to patch themselves up after the shot. Vaccinated people can’t throw a big maskless party yet — but they can celebrate a small, momentous victory. It’s fantastic.

There are still too few people vaccinated, here in the US and around the world. The rollout has been messy, and frustrating and inequitable. It still is. Governments can still do much better. But more people are getting the shot every day. In fact, Friday set vaccination records in the US and EU.

Without a doubt, that’s something to celebrate.

Here’s what else happened this week.

Research

The coronavirus is threatening a comeback. Here’s how to stop it.
Vaccination numbers are rising, but so are coronavirus variants. The pandemic isn’t over yet, but there are ways to make this next phase better than the last. (Apoorva Mandivalli / The New York Times)

Coronavirus reinfection will soon become our reality
As the virus evolves and time goes on, it’s likely that we’ll see more re-infections of the coronavirus. Here’s how that might work. (Katherine J. Wu / The Atlantic)

Coronavirus spreads readily in gyms when people don’t wear masks
A new CDC report this week looked at COVID-19 outbreaks connected to gyms. They found that indoor fitness classes that did not require people to wear masks allowed the virus to spread easily. (Amina Kahn/The Los Angeles Times)

Development

Johnson & Johnson COVID-19 vaccine backed by independent FDA committee
A single-shot vaccine got a unanimous green light from an FDA committee on Friday. The meeting came after an FDA report issued earlier this week confirmed Johnson and Johnson’s conclusions about their vaccine. (Nicole Wetsman / The Verge)

Moderna ready to test version of COVID-19 vaccine aimed at worrisome variant
Moderna is preparing to test a version of their vaccine that directly targets a particular strain of the virus. The company’s existing vaccine doesn’t work as well against this variant, so they’re developing a new version. (Damian Garde and Matthew Herper / STAT)

The growing evidence that the COVID-19 vaccines can reduce transmission, explained
When they were testing vaccines, companies looked to see if the vaccines could keep people from getting sick. And all authorized vaccines do a great job at keeping people out of the hospital and alive. But the big clinical trials weren’t designed to look at how well they can keep people from passing the disease from one person to another. It’s a big question, and one that researchers (and everyone else) is eager to uncover. (Kelsey Piper / Vox)

Perspectives

In every volunteer opportunity I’d ever been a part of, you made camp friends, formed quick alliances. To do so that day, when you even didn’t know who had been vaccinated and who hadn’t, felt aggressive and dangerous. Even holding the door open for the person behind you on the orientation tour could violate the required distance. I couldn’t discreetly murmur to my shift buddy about who was trying to cut and who was about to get out of hand.

— Irin Carmon writes about her experience as a COVID vaccine site bouncer in Brooklyn for Intelligencer.

More than Numbers

To the more than 113,507,393 people worldwide who have tested positive, may your road to recovery be smooth.

To the families and friends of the 2,519,257 people who have died worldwide — 510,467 of those in the US — your loved ones are not forgotten.

Stay safe, everyone.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending